CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) fell 0.5% during mid-day trading on Wednesday . The company traded as low as $79.65 and last traded at $80.15. 35,518 shares traded hands during trading, a decline of 52% from the average session volume of 73,281 shares. The stock had previously closed at $80.55.
CSL Stock Down 2.0%
The company has a current ratio of 1.86, a quick ratio of 0.85 and a debt-to-equity ratio of 0.45. The company has a 50-day moving average price of $78.95 and a 200-day moving average price of $80.89.
CSL Company Profile
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Read More
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
